We are live on
!
Find out more
PCM
Palouse Capital Management Portfolio holdings
AUM
$160M
1-Year Est. Return
36.15%
This Fund
S&P 500
This Quarter
Est. Return
-2.18%
1 Year Est. Return
+36.15%
3 Year Est. Return
+67.75%
5 Year Est. Return
+68.17%
10 Year Est. Return
+160.38%
AUM
$227M
AUM Growth
-$6.87M
(-2.9%)
Cap. Flow
-$1.96M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
27.69%
Holding
114
New
9
Increased
33
Reduced
56
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$6.51M |
| 2 |
Blackrock
BLK
|
+$6.46M |
| 3 |
Viatris
VTRS
|
+$4.57M |
| 4 |
Whirlpool
WHR
|
+$3.53M |
| 5 |
Best Buy
BBY
|
+$3.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$8.27M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$5.65M |
| 3 |
Lockheed Martin
LMT
|
+$5.61M |
| 4 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.58M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.58M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.14% |
| 2 | Technology | 16.57% |
| 3 | Financials | 16.01% |
| 4 | Consumer Discretionary | 10.96% |
| 5 | Consumer Staples | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPG
26
DELISTED
Interpublic Group of Companies
IPG
| $3.39M | 1.49% |
95,722
+2,351
| +3% | +$84.7K |
|
27
IBM
IBM
$224B
| $3.25M | 1.43% |
24,976
-286
| -1% | -$37.3K |
|
28
Merck
MRK
$318B
| $3.24M | 1.43% |
39,517
+56
| +0.1% | +$4.42K |
|
|
29
Best Buy
BBY
$17.3B
| $3.21M | 1.42% |
+35,365
| New | +$3.5M |
|
30
Valero Energy
VLO
$85.9B
| $3.15M | 1.38% |
30,975
+637
| +2% | +$55.3K |
|
31
Cardinal Health
CAH
$55.4B
| $3.1M | 1.36% |
54,641
+5,860
| +12% | +$314K |
|
32
Gilead Sciences
GILD
$165B
| $3.06M | 1.35% |
51,536
+1,303
| +3% | +$83.3K |
|
33
Air Products & Chemicals
APD
$67.6B
| $3.05M | 1.34% |
+12,210
| New | +$3.14M |
|
|
34
Whirlpool
WHR
$2.82B
| $3.01M | 1.32% |
+17,406
| New | +$3.53M |
|
35
FedEx
FDX
$75.4B
| $2.81M | 1.24% |
12,144
-291
| -2% | -$68.4K |
|
36
AT&T
T
$163B
| $2.8M | 1.23% |
156,648
+25,025
| +19% | +$463K |
|
|
BDXB
37
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
| $2.72M | 1.2% |
51,568
+3,863
| +8% | +$207K |
|
38
Home Depot
HD
$355B
| $2.69M | 1.18% |
8,977
+344
| +4% | +$119K |
|
39
RTX Corp
RTX
$301B
| $2.69M | 1.18% |
27,120
-891
| -3% | -$84.4K |
|
40
Lam Research
LRCX
$390B
| $2.66M | 1.17% |
49,480
+14,340
| +41% | +$835K |
|
41
Comcast
CMCSA
$90B
| $2.54M | 1.12% |
54,137
-1,497
| -3% | -$72.1K |
|
42
Alphabet (Google) Class A
GOOGL
$4.33T
| $2.51M | 1.11% |
18,060
-440
| -2% | -$59.8K |
|
43
East-West Bancorp
EWBC
$18B
| $2.49M | 1.1% |
31,502
+2,573
| +9% | +$217K |
|
44
Advanced Micro Devices
AMD
$789B
| $2.36M | 1.04% |
+21,543
| New | +$2.57M |
|
45
Lowe's Companies
LOW
$125B
| $2.35M | 1.04% |
11,644
-239
| -2% | -$55K |
|
46
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $2.23M | 0.98% |
4,929
-635
| -11% | -$283K |
|
47
Meta Platforms (Facebook)
META
$1.51T
| $2.18M | 0.96% |
9,789
+4,488
| +85% | +$1.12M |
|
|
FISV
48
Fiserv Inc
FISV
$27.9B
| $2.13M | 0.94% |
21,027
-539
| -2% | -$54.6K |
|
49
Amazon
AMZN
$2.96T
| $2.12M | 0.93% |
12,980
+2,800
| +28% | +$433K |
|
50
Regeneron Pharmaceuticals
REGN
$80.8B
| $2.08M | 0.92% |
2,985
-118
| -4% | -$74.7K |
|
Similar funds
PCC
CF
SGCM
RCWM
LCA
FPWM
SMF
RFS
Palouse Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Palouse Capital Management held 114 positions worth $227M, down 2.9% from $234M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Palouse Capital Management's Q1 2022 filing shows 9 new, 33 increased, 56 reduced and 14 closed positions. Its largest new stake was Blackrock: 8,267 shares worth $6.32M. The largest sale was AbbVie, an estimated $8.27M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
- Palouse Capital Management's largest Q1 2022 buy was Blackrock: 8,267 shares worth $6.32M.
- Palouse Capital Management added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2022, an estimated $6.51M increase.
- Palouse Capital Management's biggest Q1 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $5.58M.
- Palouse Capital Management fully exited AbbVie in Q1 2022, selling an estimated $8.27M.
- Palouse Capital Management's ten largest holdings make up 28% of its $227M portfolio in Q1 2022.
- Palouse Capital Management opened 9 new positions and closed 14 in Q1 2022.
- Palouse Capital Management's portfolio value fell 2.9% quarter-over-quarter to $227M.
Based on Palouse Capital Management's 13F filing for Q1 2022, filed 21 Apr 2022.